Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Deferred Taxes (2020 - 2024)

Historic Deferred Taxes for CureVac (CVAC) over the last 5 years, with Q2 2024 value amounting to -$432908.8.

  • CureVac's Deferred Taxes fell 137243.12% to -$432908.8 in Q2 2024 from the same period last year, while for Jun 2024 it was -$523326.5, marking a year-over-year decrease of 372626.58%. This contributed to the annual value of -$123733.1 for FY2023, which is 313193.88% down from last year.
  • Per CureVac's latest filing, its Deferred Taxes stood at -$432908.8 for Q2 2024, which was down 137243.12% from $6518.2 recorded in Q1 2024.
  • CureVac's Deferred Taxes' 5-year high stood at $112.6 million during Q4 2021, with a 5-year trough of -$1.2 million in Q4 2020.
  • Its 5-year average for Deferred Taxes is $11.1 million, with a median of -$19054.8 in 2023.
  • Its Deferred Taxes has fluctuated over the past 5 years, first soared by 925892.89% in 2021, then crashed by 137243.12% in 2024.
  • Quarter analysis of 5 years shows CureVac's Deferred Taxes stood at -$1.2 million in 2020, then skyrocketed by 9258.93% to $112.6 million in 2021, then plummeted by 100.04% to -$45911.1 in 2022, then crashed by 92.17% to -$88227.1 in 2023, then tumbled by 390.68% to -$432908.8 in 2024.
  • Its Deferred Taxes stands at -$432908.8 for Q2 2024, versus $6518.2 for Q1 2024 and -$88227.1 for Q4 2023.